Brokerage Outlooks Diverge on 2026 KOSPI — Targets Range from 4,500 to 7,500 Points

Reporter Kim Jisun / approved : 2025-11-11 08:13:33
  • -
  • +
  • 인쇄

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Kim Jisun] SEOUL, November 11, 2025 — South Korean brokerages have released widely differing forecasts for next year’s KOSPI index, reflecting diverging views on whether the market’s rebound signals a long-term bull run or a temporary recovery.


KB Securities issued the most optimistic forecast, setting its 2026 KOSPI target high at 7,500 points, citing conditions reminiscent of the 1980s “three-lows” era — low dollar, oil, and interest rates. KB expects strong earnings from semiconductor firms to drive record operating profits and views the KOSPI’s valuation as attractive compared with global peers.


At the other end, Kiwoom Securities projected a ceiling of 4,500 points, warning that U.S. tariff policies under the Trump administration and persistent inflation could weigh on equities.


Shinhan Investment Corp. placed its target at 5,000 points, while Korea Investment & Securities and Yuanta Securities each forecast 4,600 points, citing a mix of fiscal support and external risks such as U.S.–China trade tensions.


Despite short-term volatility, analysts agree that policy support and semiconductor exports will remain key drivers of market direction in 2026.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Stellantis Considers Exit from U.S. Battery Joint Venture 'StarPlus Energy' with Samsung SDI2026.02.11
Yanolja Becomes Largest Shareholder of Modetour Ahead of General Shareholder Meeting2026.02.11
Court Acquits Sampyo Group Chairman in Landmark Serious Accidents Punishment Act Case; Labor Unions Decry "License to Kill"2026.02.11
Court Acquits LG Welfare Foundation CEO Koo Yeon-kyung and Husband Yoon Kwan in Insider Trading Case2026.02.11
Concerns Grow Over Possible Drug Mix-Up in Daewoong Pharmaceutical’s Hypertension Medicine as Recall Details Remain Unclear2026.02.11
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사